ECS Screening

📍 Prilly, Switzerland👥 1 employees💰 Last funded May 2018
Biotechnology🌐 ecs-screening.ch
Website LinkedIn
Following a major scientific demonstration on the role of Progastrin in cancer development in 2003, ECS Screening has developed the first test detecting various types of cancer at an early stage : cancerREAD. After more than ten years of research, this test is now available for early screening and patient follow-up. A drug candidate is also under development.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
France
1
Frequently asked questions
Who invested in ECS Screening?
ECS Screening has 1 investors on record on gritt.io.
When did ECS Screening last raise funding?
The most recent investment in ECS Screening recorded on gritt.io was in May 2018.
What industry is ECS Screening in?
ECS Screening operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is ECS Screening based?
ECS Screening is headquartered in Prilly, Switzerland.